[
  {
    "drug_name": "Aspirin",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Aspirin",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Aspirin",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Aspirin",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Aspirin",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ibuprofen",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ibuprofen",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ibuprofen",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ibuprofen",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ibuprofen",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Acetaminophen",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Acetaminophen",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Acetaminophen",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Acetaminophen",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Acetaminophen",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Amoxicillin",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Amoxicillin",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Amoxicillin",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Amoxicillin",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Amoxicillin",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Azithromycin",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Azithromycin",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Azithromycin",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Azithromycin",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Azithromycin",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ciprofloxacin",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ciprofloxacin",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ciprofloxacin",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ciprofloxacin",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Ciprofloxacin",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Metformin",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Metformin",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Metformin",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Metformin",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Metformin",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Atorvastatin",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Atorvastatin",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Atorvastatin",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Atorvastatin",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Atorvastatin",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Lisinopril",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Lisinopril",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Lisinopril",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Lisinopril",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Lisinopril",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Omeprazole",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Omeprazole",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Omeprazole",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Omeprazole",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Omeprazole",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Levothyroxine",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Levothyroxine",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Levothyroxine",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Levothyroxine",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Levothyroxine",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Albuterol",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Albuterol",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Albuterol",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Albuterol",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Albuterol",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Gabapentin",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Gabapentin",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Gabapentin",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Gabapentin",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Gabapentin",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Sertraline",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Sertraline",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Sertraline",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Sertraline",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Sertraline",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Losartan",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Losartan",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Losartan",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Losartan",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Losartan",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin D",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin D",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin D",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin D",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin D",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin B12",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin B12",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin B12",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin B12",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin B12",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin C",
    "category": "indications",
    "section_title": "INDICATIONS & USAGE SECTION",
    "text": "Atorvastatin calcium tablets are indicated: • To reduce the risk of: o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD • As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: o Adults with primary hyperlipidemia. o Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o Primary dysbetalipoproteinemia o Hypertriglyceridemia",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin C",
    "category": "dosage",
    "section_title": "DOSAGE FORMS & STRENGTHS SECTION",
    "text": "Atorvastatin Calcium Tablets, USP: • 10 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side • 20 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side • 40 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side • 80 mg of atorvastatin: white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin C",
    "category": "contraindications",
    "section_title": "CONTRAINDICATIONS SECTION",
    "text": "Warnings and Precautions (5.3) [see ] Adverse Reactions (6.2) [see ] • Acute liver failure or decompensated cirrhosis • Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported .",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin C",
    "category": "side_effects",
    "section_title": "ADVERSE REACTIONS SECTION",
    "text": "Warnings and Precautions (5.1) [see ] Warnings and Precautions (5.2) [see ] Warnings and Precautions (5.3) [see ] Warnings and Precautions (5.4) [see ] The following important adverse reactions are described below and elsewhere in the labeling: • Myopathy and Rhabdomyolysis • Immune-Mediated Necrotizing Myopathy • Hepatic Dysfunction • Increases in HbA1c and Fasting Serum Glucose Levels",
    "source": "DailyMed"
  },
  {
    "drug_name": "Vitamin C",
    "category": "dosage",
    "section_title": "OVERDOSAGE SECTION",
    "text": "No specific antidotes for atorvastatin calcium are known. Contact Poison Control (1-800-222-1222) for latest recommendations. Due to extensive drug binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin calcium clearance.",
    "source": "DailyMed"
  }
]